Dr I Jane Cox

Publications


Journals

  • Williams HR; Willsmore JD; Cox IJ; Walker DG; Cobbold JF; Taylor-Robinson SD; Orchard TR. (10 Apr 2012). Serum Metabolic Profiling in Inflammatory Bowel Disease. Dig Dis Sci. DOI.
  • Solanky BS; Sanchez-Canon GJ; Cobbold JF; Taylor-Robinson SD; Bell JD; Scudamore CL; Ross E; Holder JC; et alSo PW; Cox IJ. (Apr 2012). Metabolic profiling of the rat liver after chronic ingestion of alpha-naphthylisothiocyanate using in vivo and ex vivo magnetic resonance spectroscopy. Toxicol Sci. 126:306-316. DOI.
  • Shariff MI; Gomaa AI; Cox IJ; Patel M; Williams HR; Crossey MM; Thillainayagam AV; Thomas HC; et alWaked I; Khan SA; Taylor-Robinson SD. (1 Apr 2011). Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study. J Proteome Res. 10:1828-1836. DOI.
  • Wylezinska M; Cobbold JF; Fitzpatrick J; McPhail MJ; Crossey MM; Thomas HC; Hajnal JV; Vennart W; et alCox IJ; Taylor-Robinson SD. (Apr 2011). A comparison of single-voxel clinical in vivo hepatic 31P MR spectra acquired at 1.5 and 3.0 Tesla in health and diseased states. NMR Biomed. 24:231-237. DOI.
  • Williams HR; Cox IJ; Walker DG; Cobbold JF; Taylor-Robinson SD; Marshall SE; Orchard TR. (2010). Differences in gut microbial metabolism are responsible for reduced hippurate synthesis in Crohn's disease. BMC Gastroenterol. 10:108. DOI.
  • Milona A; Owen BM; Cobbold JF; Willemsen EC; Cox IJ; Boudjelal M; Cairns W; Schoonjans K; et alTaylor-Robinson SD; Klomp LW; Parker MG; White R; van Mil SW; Williamson C. (Oct 2010). Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function. Hepatology. 52:1341-1349. DOI.
  • Sharif AW; Williams HR; Lampejo T; Khan SA; Bansi DS; Westaby D; Thillainayagam AV; Thomas HC; et alCox IJ; Taylor-Robinson SD. (Aug 2010). Metabolic profiling of bile in cholangiocarcinoma using in vitro magnetic resonance spectroscopy. HPB (Oxford). 12:396-402. DOI.
  • Shariff MI; Ladep NG; Cox IJ; Williams HR; Okeke E; Malu A; Thillainayagam AV; Crossey MM; et alKhan SA; Thomas HC; Taylor-Robinson SD. (5 Feb 2010). Characterization of urinary biomarkers of hepatocellular carcinoma using magnetic resonance spectroscopy in a Nigerian population. J Proteome Res. 9:1096-1103. DOI.
  • Cobbold JF; Patel JH; Goldin RD; North BV; Crossey MM; Fitzpatrick J; Wylezinska M; Thomas HC; et alCox IJ; Taylor-Robinson SD. (Jan 2010). Hepatic lipid profiling in chronic hepatitis C: an in vitro and in vivo proton magnetic resonance spectroscopy study. J Hepatol. 52:16-24. DOI.
  • Cobbold JF; Crossey MM; Colman P; Goldin RD; Murphy PS; Patel N; Fitzpatrick J; Vennart W; et alThomas HC; Cox IJ; Taylor-Robinson SD. (Aug 2010). Optimal combinations of ultrasound-based and serum markers of disease severity in patients with chronic hepatitis C. J Viral Hepat. 17:537-545. DOI.
  • Winston A; Garvey L; Scotney E; Yerrakalva D; Allsop JM; Thomson EC; Grover VP; Main J; et alCox JI; Wylezinska M; Taylor-Robinson SD. (Jun 2010). Does acute hepatitis C infection affect the central nervous system in HIV-1 infected individuals?. J Viral Hepat. 17:419-426. DOI.
  • Shariff MI; Cox IJ; Gomaa AI; Khan SA; Gedroyc W; Taylor-Robinson SD. (Aug 2009). Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol. 3:353-367. DOI.
  • Williams HRT; Cox IJ; Walker DG; North BV; Patel VM; Marshall SE; Jewell DP; Ghosh S; et alThomas HJW; Teare JP; Jakobovits S; Zeki S; Welsh KI; Taylor-Robinson SD; Orchard TR. (1 Jul 2009). Characterization of Inflammatory Bowel Disease With Urinary Metabolic Profiling (vol 104, pg 1435, 2009). AMERICAN JOURNAL OF GASTROENTEROLOGY. 104:1894-1894. Author weblink DOI.
  • Adenugba A; Khan SA; Taylor-Robinson SD; Cox IJ; Toledano MB; Thillainayagam AV; Bansi DS; Thomas HC; et alGibson RW; Beck AJ. (Aug 2009). Polychlorinated biphenyls in bile of patients with biliary tract cancer. Chemosphere. 76:841-846. DOI.
  • Williams HR; Cox IJ; North BV; Patel VM; Marshall SE; Jewell DP; Ghosh S; Thomas HJ; et alTeare JP; Jakobovits S; Zeki SS; Welsh KI; Taylor-Robinson SD; Orchard T. (1 Apr 2008). Crohn's disease is associated with a specific urinary metabolic profile. GASTROENTEROLOGY. 134:A195-A195. Author weblink.
  • Williams HR; Cox IJ; Walker DG; North BV; Patel VM; Marshall SE; Jewell DP; Ghosh S; et alThomas HJ; Teare JP; Jakobovits S; Zeki S; Welsh KI; Taylor-Robinson SD; Orchard TR. (Jun 2009). Characterization of inflammatory bowel disease with urinary metabolic profiling. Am J Gastroenterol. 104:1435-1444. DOI.
  • Cobbold JF; Anstee QM; Goldin RD; Williams HR; Matthews HC; North BV; Absalom N; Thomas HC; et alThursz MR; Cox RD; Taylor-Robinson SD; Cox IJ. (Mar 2009). Phenotyping murine models of non-alcoholic fatty liver disease through metabolic profiling of intact liver tissue. Clin Sci (Lond). 116:403-413. DOI.
  • Cobbold JFL; Taylor-Robinson SD; Cox IJ. (1 Sep 2008). In vitro proton magnetic resonance spectroscopy of liver tissue informs in vivo hepatic proton magnetic resonance spectroscopy studies. HEPATOLOGY. 48:1016-1016. Author weblink DOI.
  • Williams HRT; Cox IJ; Taylor-Robinson SD. (1 Sep 2008). Metabonomics in hepatic encephalopathy: lucidity emerging from confusion. LIVER INTERNATIONAL. 28:1050-1051. Author weblink DOI.
  • Cobbold JF; Wylezinska M; Cunningham C; Crossey ME; Thomas HC; Cox IJ; Patel N; Taylor-Robinson SD. (Nov 2006). Non-invasive evaluation of hepatic fibrosis using magnetic resonance and ultrasound techniques. Gut. 55:1670.
  • Cox IJ; Sharif A; Cobbold JF; Thomas HC; Taylor-Robinson SD. (14 Aug 2006). Current and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease. World J Gastroenterol. 12:4773-4783.
  • Cox IJ; Sharif A; Cobbold JFL; Thomas HC; Taylor-Robinson SD. (14 Aug 2006). Current and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease. WORLD J GASTROENTERO. 12:4773-4783.
  • Cheong JLY; Cady EB; Penrice J; Wyatt JS; Cox IJ; Robertson NJ. (1 Aug 2006). Proton MR spectroscopy in neonates with perinatal cerebral hypoxic-ischemic injury: Metabolite peak-area ratios, relaxation times, and absolute concentrations. AMERICAN JOURNAL OF NEURORADIOLOGY. 27:1546-1554. Author weblink.
  • Grier S; Lim AK; Patel N; Cobbold JF; Thomas HC; Cox IJ; Taylor-Robinson SD. (14 Jun 2006). Role of microbubble ultrasound contrast agents in the non-invasive assessment of chronic hepatitis C-related liver disease. World J Gastroenterol. 12:3461-3465.
  • Cobbold, J; Lim A; Wylezinska M; Cunningham C; Crossey M; Thomas H; Patel N; Cox J; et alTaylor-Robinson. (Jun 2006). Magnetic resonance and ultrasound techniques for the evaluation of hepatic fibrosis. Hepatology. 6, 43:1401-1402. Author weblink.
  • Forton DA; Allsop JA; Cox IJ; Hamilton G; Wesnes K; Thomas HC; Taylor-Robinson SD. (1 Oct 2005). A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection. AIDS. 19:S53-S63. Author weblink DOI.
  • Robertson NJ; Bhakoo K; Puri BK; Edwards AD; Cox IJ. (Aug 2005). Hypothermia and amiloride preserve energetics in a neonatal brain slice model. Pediatr Res. 58:288-296. DOI.
  • Khan SA; Thomas HC; Toledano MB; Cox IJ; Taylor-Robinson SD. (Aug 2005). p53 Mutations in human cholangiocarcinoma: a review. Liver Int. 25:704-716. DOI.
  • Khan SA; Cox IJ; Thillainayagam AV; Bansi DS; Thomas HC; Taylor-Robinson SD. (1 Jul 2005). Proton and phosphorus-31 nuclear magnetic resonance spectroscopy of human bile in hepatopancreaticobiliary cancer. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. 17:733-738. Author weblink DOI.
  • Khan SA; Cox IJ; Hamilton G; Thomas HC; Taylor-Robinson SD. (Apr 2005). In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications. Liver Int. 25:273-281. DOI.
  • Damelin LH; Coward S; Choudhury SF; Chalmers SA; Cox IJ; Robertson NJ; Revial G; Miles M; et alTootle R; Hodgson HJF; Selden C. (15 Dec 2004). Altered mitochondrial function and cholesterol synthesis influences protein synthesis in extended HepG2 spheroid cultures. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 432:167-177. Author weblink DOI.
  • Dave U; Taylor-Robinson SD; Walker MM; Mahon M; Puri BK; Thursz MR; DeSouza NM; Cox IJ. (Nov 2004). In vitro 1H-magnetic resonance spectroscopy of Barrett's esophageal mucosa using magic angle spinning techniques. Eur J Gastroenterol Hepatol. 16:1199-1205.
  • Mahon MM; deSouza NM; Dina R; Soutter WP; McIndoe GA; Williams AD; Cox IJ. (May 2004). Preinvasive and invasive cervical cancer: an ex vivo proton magic angle spinning magnetic resonance spectroscopy study. NMR Biomed. 17:144-153. DOI.
  • Cox IJ; Puri BK. (Apr 2004). In vivo MR spectroscopy in diagnosis and research of neuropsychiatric disorders. Prostaglandins Leukot Essent Fatty Acids. 70:357-360. DOI.
  • Mahon MM; Cox IJ; Dina R; Soutter WP; McIndoe GA; Williams AD; deSouza NM. (Mar 2004). (1)H magnetic resonance spectroscopy of preinvasive and invasive cervical cancer: in vivo-ex vivo profiles and effect of tumor load. J Magn Reson Imaging. 19:356-364. DOI.
  • Mahon MM; Williams AD; Soutter WP; Cox IJ; McIndoe GA; Coutts GA; Dina R; deSouza NM. (Feb 2004). 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration. NMR Biomed. 17:1-9. DOI.
  • Robertson NJ; Stafler P; Battini R; Cheong J; Tosetti M; Bianchi MC; Cox IJ; Cowan FM; et alCioni G. (Feb 2004). Brain lactic alkalosis in Aicardi-Goutières syndrome. Neuropediatrics. 35:20-26. DOI.
  • Bhakoo KK; Bell JD; Cox IJ; Taylor-Robinson SD. (2004). The application of magnetic resonance imaging and spectroscopy to gene therapy. Methods Enzymol. 386:303-313. DOI.
  • Dhanjal NS; Cox IJ; Taylor-Robinson SD. (Sep 2003). In vivo electron spin resonance spectroscopy: what use is it to gastroenterologists?. Gut. 52:1236-1237.
  • Robertson NJ; Cowan FM; Cox IJ; Edwards AD. (Dec 2002). Brain alkaline intracellular pH after neonatal encephalopathy. Ann Neurol. 52:732-742. DOI.
  • Robertson NJ; Lewis RH; Cowan FM; Allsop JM; Counsell SJ; Edwards AD; Cox IJ. (Dec 2001). Early increases in brain myo-inositol measured by proton magnetic resonance spectroscopy in term infants with neonatal encephalopathy. Pediatr Res. 50:692-700.
  • Richardson AJ; Allen SJ; Hajnal JV; Cox IJ; Easton T; Puri BK. (Nov 2001). Associations between central and peripheral measures of phospholipid breakdown revealed by cerebral 31-phosphorus magnetic resonance spectroscopy and fatty acid composition of erythrocyte membranes. Prog Neuropsychopharmacol Biol Psychiatry. 25:1513-1521.
  • Changani KK; Jalan R; Cox IJ; Ala-Korpela M; Bhakoo K; Taylor-Robinson SD; Bell JD. (Oct 2001). Evidence for altered hepatic gluconeogenesis in patients with cirrhosis using in vivo 31-phosphorus magnetic resonance spectroscopy. Gut. 49:557-564.
  • Robertson NJ; Kuint J; Counsell TJ; Rutherford TA; Coutts A; Cox IJ; Edwards AD. (Oct 2000). Characterization of cerebral white matter damage in preterm infants using 1H and 31P magnetic resonance spectroscopy. J Cereb Blood Flow Metab. 20:1446-1456. DOI.
  • Robertson NJ; Lewis RH; Cowan FM; Rutherford MA; Allsop JM; Cox IJ; Edwards AD. (1 Apr 2000). Early increases in brain myo-inositol measured by proton (H-1) magnetic resonance spectroscopy (MRS) in term infants with neonatal encephalopathy. PEDIATRIC RESEARCH. 47:429A-429A. Author weblink.
  • Robertson NJ; Kuint J; Counsell J; Cowan FM; Rutherford MA; Cox IJ; Edwards AD. (1 Apr 2000). White matter damage in the preterm infant: Characterization using proton (H-1) and phosphorus (P-31) magnetic resonance spectroscopy. PEDIATRIC RESEARCH. 47:429A-429A. Author weblink.
  • Mathur R; Cox IJ; Oatridge A; Shephard DT; Shaw RJ; Taylor-Robinson SD. (Dec 1999). Cerebral bioenergetics in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 160:1994-1999.
  • Marcus CD; Taylor-Robinson SD; Cox IJ; Sargentoni J; Shaunak S. (Dec 1999). Reversible alterations in brain metabolites during therapy for disseminated nocardiosis using proton magnetic resonance spectroscopy. Metab Brain Dis. 14:231-237.
  • Robertson NJ; Cox IJ; Cowan FM; Counsell SJ; Azzopardi D; Edwards AD. (Sep 1999). Cerebral intracellular lactic alkalosis persisting months after neonatal encephalopathy measured by magnetic resonance spectroscopy. Pediatr Res. 46:287-296.
  • Robertson NJ; Cox IJ; Cowan FM; Counsell SJ; Azzopardi D; Edwards AD. (1 Jun 1999). Cerebral lactic alkalosis persisting months after birth asphyxia. PEDIATRIC RESEARCH. 45:909-909. Author weblink DOI.
  • Taylor-Robinson SD; Turjanski N; Bhattacharya S; Seery JP; Sargentoni J; Brooks DJ; Bryant DJ; Cox IJ. (Mar 1999). A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease. Metab Brain Dis. 14:45-55.
  • Hanrahan JD; Cox IJ; Azzopardi D; Cowan FM; Sargentoni J; Bell JD; Bryant DJ; Edwards AD. (Feb 1999). Relation between proton magnetic resonance spectroscopy within 18 hours of birth asphyxia and neurodevelopment at 1 year of age. Dev Med Child Neurol. 41:76-82.
  • Puri BK; Smith HC; Cox IJ; Sargentoni J; Savic G; Maskill DW; Frankel HL; Ellaway PH; et alDavey NJ. (Nov 1998). The human motor cortex after incomplete spinal cord injury: an investigation using proton magnetic resonance spectroscopy. J Neurol Neurosurg Psychiatry. 65:748-754.
  • Hanrahan JD; Cox IJ; Edwards AD; Cowan FM; Sargentoni J; Bell JD; Bryant DJ; Rutherford MA; et alAzzopardi D. (Sep 1998). Persistent increases in cerebral lactate concentration after birth asphyxia. Pediatr Res. 44:304-311.
  • Taylor-Robinson SD; Sargentoni J; Bell JD; Thomas EL; Marcus CD; Changani KK; Saeed N; Hodgson HJ; et alDavidson BR; Burroughs AK; Rolles K; Foster CS; Cox IJ. (May 1998). In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts. Gut. 42:735-743.
  • Richardson AJ; Cox IJ; Sargentoni J; Puri BK. (Oct 1997). Abnormal cerebral phospholipid metabolism in dyslexia indicated by phosphorus-31 magnetic resonance spectroscopy. NMR Biomed. 10:309-314.
  • Jalan R; Cox IJ; Wilson JW; AlaKorpela M; Schweiso J; Bell JD. (1 Oct 1997). Functional in vivo hepatic 31-phosphorus magnetic resonance spectroscopy after administration of L-alanine: Direct measurement of hepatic gluconeogenesis in patients with cirrhosis of varying severity. HEPATOLOGY. 26:1011-1011. Author weblink.
  • Taylor-Robinson SD; Sargentoni J; Bell JD; Saeed N; Changani KK; Davidson BR; Rolles K; Burroughs AK; et alHodgson HJ; Foster CS; Cox IJ. (Aug 1997). In vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. Liver. 17:198-209.
  • Hajnal JV; Roberts I; Wilson J; Oatridge A; Saeed N; Cox IJ; Ala-Korpela M; Bydder GM; et alYoung IR. (Oct 1996). Effect of profound ischaemia on human muscle: MRI, phosphorus MRS and near-infrared studies. NMR Biomed. 9:305-314. DOI.
  • Jalan R; Cox IJ; Wilson J; AlaKorpela M; Schweiso J; Bell JD. (1 Oct 1996). In vivo hepatic phosphorus-31 magnetic resonance spectroscopy after infusion of L-alanine: Understanding the biochemical basis of hepatic decompensation. HEPATOLOGY. 24:57-57. Author weblink.
  • Hanrahan JD; Sargentoni J; Azzopardi D; Manji K; Cowan FM; Rutherford MA; Cox IJ; Bell JD; et alBryant DJ; Edwards AD. (Apr 1996). Cerebral metabolism within 18 hours of birth asphyxia: a proton magnetic resonance spectroscopy study. Pediatr Res. 39:584-590.
  • JALAN R; SARGENTONI J; BRYANT DJ; COUTTS GA; BELL JD; COX IJ; ROLLES K; BURROUGHS AK; et alTAYLORROBINSON SD; STEINER RE. (1 Oct 1995). ASSESSMENT OF IN-VIVO HEPATIC P-31 MAGNETIC-RESONANCE SPECTROSCOPY AS A PROGNOSTIC MARKER IN PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS. HEPATOLOGY. 22:68-68. Author weblink.
  • Chung YL; Williams A; Beech JS; Williams SC; Bell JD; Cox IJ; Hope J. (Jun 1995). MRI assessment of the blood-brain barrier in a hamster model of scrapie. Neurodegeneration. 4:203-207.
  • Menon DK; Harris M; Sargentoni J; Taylor-Robinson SD; Cox IJ; Morgan MY. (Mar 1995). In vivo hepatic 31P magnetic resonance spectroscopy in chronic alcohol abusers. Gastroenterology. 108:776-788.
  • Menon DK; Sargentoni J; Taylor-Robinson SD; Bell JD; Cox IJ; Bryant DJ; Coutts GA; Rolles K; et alBurroughs AK; Morgan MY. (Feb 1995). Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology. 21:417-427.
  • Menon DK; Lockwood GG; Peden CJ; Cox IJ; Sargentoni J; Bell JD; Coutts GA; Whitwam JG. (Dec 1993). In vivo fluorine-19 magnetic resonance spectroscopy of cerebral halothane in postoperative patients: preliminary results. Magn Reson Med. 30:680-684.
  • Bell JD; Cox IJ; Sargentoni J; Peden CJ; Menon DK; Foster CS; Watanapa P; Iles RA; et alUrenjak J. (25 Nov 1993). A 31P and 1H-NMR investigation in vitro of normal and abnormal human liver. Biochim Biophys Acta. 1225:71-77.
  • PEDEN CJ; RUTHERFORD MA; SARGENTONI J; COX IJ; BRYANT DJ; DUBOWITZ LMS. (1 Jun 1993). PROTON SPECTROSCOPY OF THE NEONATAL BRAIN FOLLOWING HYPOXIC-ISCHEMIC INJURY. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY. 35:502-510. Author weblink.
  • DAGNELIE PC; BELL JD; COX IJ; MENON DK; SARGENTONI J; COUTTS GA; WILLIAMS SCR. (1 Mar 1993). EFFECTS OF FISH OIL ON PHOSPHOLIPID-METABOLISM IN HUMAN AND RAT-LIVER STUDIED BY P-31 NMR-SPECTROSCOPY INVIVO AND INVITRO. NMR IN BIOMEDICINE. 6:157-162. Author weblink DOI.
  • Dagnelie PC; Menon DK; Cox IJ; Bell JD; Sargentoni J; Coutts GA; Urenjak J; Iles RA. (Aug 1992). Effect of L-alanine infusion on 31P nuclear magnetic resonance spectra of normal human liver: towards biochemical pathology in vivo. Clin Sci (Lond). 83:183-190.
  • Menon DK; Ainsworth JG; Cox IJ; Coker RC; Sargentoni J; Coutts GA; Baudouin CJ; Kocsis AE; et alHarris JR. (Jul 1992). Proton MR spectroscopy of the brain in AIDS dementia complex. J Comput Assist Tomogr. 16:538-542.
  • Cox IJ; Bell JD; Peden CJ; Iles RA; Foster CS; Watanapa P; Williamson RC. (May 1992). In vivo and in vitro 31P magnetic resonance spectroscopy of focal hepatic malignancies. NMR Biomed. 5:114-120.
  • COX IJ; MENON DK; SARGENTONI J; BRYANT DJ; COLLINS AG; COUTTS GA; ILES RA; BELL JD; et alBENJAMIN IS; GILBEY S; HODGSON HJF; MORGAN MY. (1 Mar 1992). P-31 MAGNETIC-RESONANCE SPECTROSCOPY OF THE HUMAN LIVER USING CHEMICAL-SHIFT IMAGING TECHNIQUES. JOURNAL OF HEPATOLOGY. 14:265-275. DOI.
  • Bell JD; Cox IJ; Williams SC; Belton PS; McConnell I; Hope J. (Oct 1991). In vivo detection of metabolic changes in a mouse model of scrapie using nuclear magnetic resonance spectroscopy. J Gen Virol. 72 ( Pt 10):2419-2423.
  • BELL JD; COX IJ; WILLIAMS SCR; BELTON PS; MCCONNELL I; HOPE J. (1 Oct 1991). INVIVO DETECTION OF METABOLIC CHANGES IN A MOUSE MODEL OF SCRAPIE USING NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY. JOURNAL OF GENERAL VIROLOGY. 72:2419-2423. Author weblink DOI.
  • Cox IJ; Coutts GA; Gadian DG; Ghosh P; Sargentoni J; Young IR. (Jan 1991). Saturation effects in phosphorus-31 magnetic resonance spectra of the human liver. Magn Reson Med. 17:53-61.
  • BAUDOUIN CJ; BRYANT DJ; COLLINS AG; COUTTS GC; COX IJ; HAJNAL JV; MENON DK; PAGE DR; et alYOUNG IR. (15 Dec 1990). ASPECTS OF CHEMICAL-SHIFT IMAGING WHICH ILLUSTRATE THE CROSS-FERTILIZATION OF METHODS AND TECHNIQUES IN INVIVO NMR IMAGING AND SPECTROSCOPY. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES. 333:545-559. Author weblink DOI.
  • Peden CJ; Cowan FM; Bryant DJ; Sargentoni J; Cox IJ; Menon DK; Gadian DG; Bell JD; et alDubowitz LM. (Nov 1990). Proton MR spectroscopy of the brain in infants. J Comput Assist Tomogr. 14:886-894.
  • GILL SS; THOMAS DGT; VANBRUGGEN N; GADIAN DG; PEDEN CJ; BELL JD; COX IJ; MENON DK; et alILES RA; BRYANT DJ; COUTTS GA. (1 Jul 1990). PROTON MR SPECTROSCOPY OF INTRACRANIAL TUMORS - INVIVO AND INVITRO STUDIES. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY. 14:497-504. Author weblink DOI.
  • Menon DK; Sargentoni J; Peden CJ; Bell JD; Cox IJ; Coutts GA; Baudouin C; Newman CG. (May 1990). Proton MR spectroscopy in herpes simplex encephalitis: assessment of neuronal loss. J Comput Assist Tomogr. 14:449-452.
  • Young IR; Cox IJ; Coutts GA; Bydder GM. (Dec 1989). Some considerations concerning susceptibility, longitudinal relaxation time constants and motion artifacts in vivo human spectroscopy. NMR Biomed. 2:329-339.
  • COX IJ; BRYANT DJ; YOUNG IR. (1 Sep 1988). MAGNETIC-RESONANCE SPECTROSCOPY IN LIVER-DISEASE. BRITISH JOURNAL OF RADIOLOGY. 61:876-876. Author weblink.
  • COX IJ. (1 Sep 1988). NUCLEAR MAGNETIC-RESONANCE SPECTROSCOPY. BRITISH JOURNAL OF HOSPITAL MEDICINE. 40:165-165. Author weblink.
  • BRYANT DJ; BYDDER GM; CASE HA; COLLINS AG; COX IJ; MAKEPEACE A; PENNOCK JM. (1 Sep 1988). USE OF P-31 MR SPECTROSCOPY TO MONITOR RESPONSE TO CHEMOTHERAPY IN NON-HODGKIN LYMPHOMA. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY. 12:770-774. Author weblink DOI.
  • BRYANT DJ; YOUNG IR; SARGENTONI J; COX IJ; COUTTS G; ILES RA. (1 Aug 1988). EVALUATION OF HUMAN-TUMORS, INVIVO, USING PHASE ENCODING MR TECHNIQUES. TUMORDIAGNOSTIK & THERAPIE. 9:165-165. Author weblink.
  • COX IJ; BRYANT DJ; COLLINS AG; GEORGE P; HARMAN RR; HALL AS; HODGSON HJF; KHENIA S; et alMCARTHUR P; SPENCER DH; YOUNG IR. (1 May 1988). 4-DIMENSIONAL CHEMICAL-SHIFT MR IMAGING OF PHOSPHORUS METABOLITES OF NORMAL AND DISEASED HUMAN-LIVER. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY. 12:369-376. Author weblink.
  • BAILES DR; BRYANT DJ; CASE HA; COLLINS AG; COX IJ; HALL AS; HARMAN RR; KHENIA S; et alMCARTHUR P; ROSS BD; YOUNG IR. (1 May 1988). INVIVO IMPLEMENTATION OF 3-DIMENSIONAL PHASE-ENCODED SPECTROSCOPY WITH A CORRECTION FOR FIELD INHOMOGENEITY. JOURNAL OF MAGNETIC RESONANCE. 77:460-470. Author weblink DOI.
  • Cox IJ; Sargentoni J; Calam J; Bryant DJ; Iles RA. (Feb 1988). Four-dimensional phosphorus-31 chemical shift imaging of carcinoid metastases in the liver. NMR Biomed. 1:56-60.
  • Ross B; Helsper JT; Cox IJ; Young IR; Kempf R; Makepeace A; Pennock J. (Dec 1987). Osteosarcoma and other neoplasms of bone. Magnetic resonance spectroscopy to monitor therapy. Arch Surg. 122:1464-1469.
  • ROSS BD; MORGAN MY; COX IJ; HAWLEY KE; YOUNG IR. (1 Aug 1987). CONTINUING DEFECT IN CEREBRAL ENERGY-METABOLISM IN PATIENTS WITH PERSISTENT HEPATIC-ENCEPHALOPATHY - MONITORING WITH P-31 MAGNETIC-RESONANCE SPECTROSCOPY. BRITISH JOURNAL OF RADIOLOGY. 60:847-847. Author weblink.
  • ROSS BD; BAILES DR; BRYANT DJ; BYDDER GM; CASE HA; COX IJ; HODGSON H; MORGAN M; et alROBINSON D; YOUNG IR. (1 Aug 1987). ENERGY-METABOLISM OF NORMAL AND PATHOLOGICAL LIVER IN MAN DEMONSTRATED BY P-31 MAGNETIC-RESONANCE SPECTROSCOPY. BRITISH JOURNAL OF RADIOLOGY. 60:848-848. Author weblink.
  • BAILES DR; BRYANT DJ; BYDDER GM; CASE HA; COLLINS AG; COX IJ; EVANS PR; HARMAN RR; et alHALL AS; KHENIA S; MCARTHUR P; OLIVER A; ROSE MR; ROSS BD; YOUNG IR. (1 Aug 1987). LOCALIZED P-31 NMR-SPECTROSCOPY OF NORMAL AND PATHOLOGICAL HUMAN ORGANS INVIVO USING PHASE-ENCODING TECHNIQUES. JOURNAL OF MAGNETIC RESONANCE. 74:158-170. Author weblink DOI.
  • BAILES DR; BRYANT DJ; BYDDER GM; CASE HA; COLLINS AG; COX IJ; HARMAN RR; HALL AS; et alKHENIA S; MCARTHUR P; ROSS BD; YOUNG IR. (1 Aug 1987). LOCALIZED P-31 SPECTROSCOPY INVIVO USING PHASE ENCODING NUCLEAR-MAGNETIC-RESONANCE TECHNIQUES. BRITISH JOURNAL OF RADIOLOGY. 60:787-787. Author weblink.
  • ROSS BD; COX IJ; PENNOCK J; CASE HA; YOUNG IR; BAILES DR; BRYANT DJ; MAKEPEACE A; et alPRINGLE J; SWEETNAM AN. (1 Aug 1987). OSTEOSARCOMA AND OTHER NEOPLASMS OF BONE - A POSSIBLE CONTRIBUTION OF P-31 MAGNETIC-RESONANCE SPECTROSCOPY TO THERAPEUTIC MONITORING. BRITISH JOURNAL OF RADIOLOGY. 60:810-810. Author weblink.
  • COX IJ; THOMAS DB; DAVIES C; YOUNG IR; BYDDER GM; BAILES DR; BRYANT DJ; ROSS BD; et alKHENIA S. (1 Aug 1987). P-31 MAGNETIC-RESONANCE SPECTROSCOPY IN CEREBRAL NEOPLASMS - A COMBINED STUDY USING MAGNETIC-RESONANCE-IMAGING AND COMPUTED-TOMOGRAPHY. BRITISH JOURNAL OF RADIOLOGY. 60:795-795. Author weblink.
  • YOUNG IR; COX IJ; BYDDER GM; HALL AS; GADIAN DG; ROSS BD. (1 Aug 1987). POTENTIAL EFFECTS OF SUSCEPTIBILITY VARIATIONS IN PATHOLOGICAL TISSUE ON THE QUALITY OF SPECTROSCOPIC STUDIES. BRITISH JOURNAL OF RADIOLOGY. 60:786-786. Author weblink.
  • Cox IJ; Bryant DJ; Ross BD; Young IR; Gadian DG; Bydder GM; Williams SR; Busza AL; et alBates TE. (Aug 1987). Spectral resolution in clinical magnetic resonance spectroscopy. Magn Reson Med. 5:186-190.
  • YOUNG IR; KHENIA S; THOMAS DGT; DAVIS CH; GADIAN DG; COX IJ; ROSS BD; BYDDER GM. (1 Jan 1987). CLINICAL MAGNETIC-SUSCEPTIBILITY MAPPING OF THE BRAIN. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY. 11:2-6. Author weblink DOI.
  • BYDDER GM; PAYNE JA; COLLINS AG; THOMAS DGT; DAVIS CH; COX IJ; ROSS BD; YOUNG IR. (1 Jan 1987). CLINICAL USE OF RAPID T2 WEIGHTED PARTIAL SATURATION SEQUENCES IN MR IMAGING. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY. 11:17-23. Author weblink DOI.
  • BELTON PS; COX IJ; HARRIS RK. (1 Nov 1986). LINE WIDTHS, SENSITIVITY AND ARTIFACTS IN S-33 NMR-SPECTRA - THE CASE OF AQUEOUS SULFIDES. MAGNETIC RESONANCE IN CHEMISTRY. 24:1004-1007. Author weblink DOI.
  • COX IJ; BYDDER GM; GADIAN DG; YOUNG IR; PROCTOR E; WILLIAMS S; HART I. (15 Oct 1986). THE EFFECT OF MAGNETIC-SUSCEPTIBILITY VARIATIONS IN NMR IMAGING AND NMR-SPECTROSCOPY INVIVO. JOURNAL OF MAGNETIC RESONANCE. 70:163-168. Author weblink DOI.
  • ROSS BD; MORGAN HY; COX IJ; HAWLEY KM; YOUNG IR. (1 Jan 1987). CONTINUING DEFECT IN CEREBRAL ENERGY-METABOLISM IN PATIENTS WITH PERSISTENT HEPATIC-ENCEPHALOPATHY (PHE) - MONITORING WITH P-31 MRS. CLINICAL SCIENCE. 72:P26-P26. Author weblink.

Books

  • So PW; Bhakoo KK; Cox IJ; Taylor-Robinson SD; Bell JD. Conn PM (ed). Essential Bioimaging Methods (Chapter 18: The application of magnetic resonance imaging and spectroscopy to gene therapy). 373-397. Academic Press, Burlington (1 Nov 2009).

Chapters in books

  • Sharif AW; Khan SA; Lindley CM; Lampejo TL; Goldin RJ; Cox IJ; Taylor-Robinson SD. Cholangiocarcinoma. In Liver: A Complete Book on Hepato-Pancreato-Biliary Diseases. 596-607. Mahtab (ed). Elsevier India (1 Jan 2009).
  • So PW; Bhakoo KK; Cox IJ; Taylor-Robinson SD; Bell JD. The application of magnetic resonance imaging and spectroscopy to gene therapy. In Essential Bioimaging Methods. 373-397. Conn PM (ed). Academic Press, Burlington (26 Oct 2009).
  • Taylor-Robinson SD; Cobbold JFL; Crossey MME; Cox IJ. To perform a liver biopsy or not? Possible non-invasive alternatives. In Horizons in Medicine. 21:103-112. Royal College of Physicians of London, London (2009).
  • Lim AK; Khan SA; Cox IJ; Taylor-Robinson SD. Nuclear magnetic resonance spectroscopy of in the study of human liver. In Nuclear magnetic resonance spectroscopy in the study of neoplastic tissue. 295-311. Tosi R (ed); Tugnoli V (ed). Nova Science, Hauppauge, New York (1 Jan 2005).
  • Forton DM; Taylor-Robinson SD; Cox IJ; Thomas HC. Central nervous system complications. In Viral hepatitis. 3:482-495. Thomas HC (ed); Lemon SM (ed); Zuckerman AJ (ed). Blackwell, Oxford (2005).
  • Sharif AW; Khan SA; Lindley CM; Lampejo TM; Goldin RD; Cox IJ; Taylor-Robinson SD. Cholangiocarcinoma. In Liver: A Complete Book on Hepato-Pancreato-Biliary Diseases. 596-607. Al-Mahtab M (ed); Rahman S (ed). Elsevier, Noida (2009).
  • Forton DM; Taylor-Robinson SD; Cox IJ; Thomas HC. Central nervous system complications. In Viral Hepatitis. 3rd, 29:482-495. Thomas HC (ed); Lemon S (ed); Zuckerman A (ed). Blackwell Publishing Ltd, Oxford (2005).
  • Lim AKP; Khan SA; Cox IJ; Taylor-Robinson SD. Nuclear Magnetic Resonance Spectroscopy in the Study of Human Liver. In Nuclear Magnetic Resonance Spectroscopy in the Study of Neoplastic Tissue. 295-312. Tosi (ed); R (ed); Tugnoli (ed); V (ed). Nova Science Publishers Inc., New York (2005).
  • Bhakoo KK; Bell JD; Cox IJ; Taylor-Robinson SD. The application of magnetic resonance imaging and spectroscopy to gene therapy. In Methods Enzymol. 13-303. Conn MP (ed). Elsevier Academic Press (2004).
  • Robertson NJ; Cox IJ. Magnetic resonance spectroscopy of the neonatal brain. In Magnetic Resonance Imaging of the Neonatal Brain. 295-314. Rutherford MA (ed). WB Saunders (2002).
  • Patay Z; Robertson NJ; Cox IJ. Metabolic disorders of the newborn. In Magnetic Resonance Imaging of the Neonatal Brain. 315-348. Rutherford MA (ed). WB Saunders (2002).
  • Cox IJ. Liver in vivo magnetic resonance spectroscopy of humans. In Methods in Biomedical Magnetic Resonance Imaging and Spectroscopy. Young IR (ed); Grant DM (ed); Harris RK (ed). John Wiley & Sons, Chichester (Oct 2000).
  • Cox IJ. Liver in vivo magnetic resonance spectroscopy of humans. In Encyclopedia of nuclear magnetic resonance. Grant DM (ed); Harris RK (ed). John Wiley & Sons, Chichester (1996).

Conferences

  • Williams HRT; Cox IJ; Walker DG; Sato H; Taylor-Robinson SD; Marshall SE; Orchard TR. CORRELATING URINARY METABOLIC PROFILES WITH SEROLOGICAL AND GENETIC DETERMINANTS OF INFLAMMATORY BOWEL DISEASE. Annual General Meeting of the British-Society-of-Gastroenterology, 22 Mar 2010 - 25 Mar 2010. 59:A67-A68. B M J PUBLISHING GROUP (1 Apr 2010). DOI.
  • Williams HRT; Cox I; North BV; Patel VM; Marshall SE; Jewell DP; Ghosh S; Thomas HJW; et alTeare JP; Jakobovits S; Zeki S; Welsh KI; Taylor-Robinson SD; Orchard TR. A urinary metabolic profile associated with Crohn's disease. Conference of the Scottish-Society-of-Gastroenterology-Audit on the Use of Adalimumab in the Management of Crohn's Disease. 57:A153-A153. (Jan 2008).
  • Parviz N; Edwards RJ; Wasan HS; Taylor-Robinson SD; Toledano MB; Cox J; Khan S. PLASMA PROTEOMIC PROFILING OF PATIENTS WITH CHOLANGIOCARCINOMA. 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, 31 Oct 2008 - 4 Nov 2008. 48:984A-985A. JOHN WILEY & SONS INC (1 Oct 2008). Author weblink.
  • Nassim P; Edwards RJ; Wasan H; Cox I; Toledano MB; Taylor-Robinson SD; Khan SA. PLASMA PROTEOMIC PROFILING OF PATIENTS WITH CHOLANGIOCARCINOMA. Annual Meeting of the British-Society-of-Gastroenterology, 23 Mar 2009 - 26 Mar 2009. 58:A17-A17. B M J PUBLISHING GROUP (1 Apr 2009).
  • Adenugba A; Khan SA; Taylor-Robinson SD; Cox IJ; Toledano MB; Thillainayagam AV; Bansi DS; Gibson RW; et alThomas HC; Beck AC. POLYCHLORINATED BIPHENYLS IN BILE OF PATIENTS WITH BILIARY TRACT CANCER. 44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, 22 Apr 2009 - 26 Apr 2009. 50:S188-S188. ELSEVIER SCIENCE BV (1 Jan 2009). Author weblink.
  • Cobbold JFL; Patel JH; Goldin RD; Crossey ME; Fitzpatrick I; Taylor-Robinson SD; Cox IJ. NON-INVASIVE ASSESSMENT OF HEPATIC LIPID COMPOSITION: LIPID POLYUNSATURATION DECREASES WITH INCREASING FIBROSIS IN CHRONIC HEPATITIS C. 44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, 22 Apr 2009 - 26 Apr 2009. 50:S149-S150. ELSEVIER SCIENCE BV (1 Jan 2009). Author weblink.
  • Walker DG; Williams HRT; Cox IJ; Orchard TR. URINARY METABOLIC PROFILING IN CROHN'S DISEASE: IS THERE A DIFFERENCE BETWEEN ETHNIC GROUPS?. Annual Meeting of the British-Society-of-Gastroenterology, 23 Mar 2009 - 26 Mar 2009. 58:A60-A60. B M J PUBLISHING GROUP (1 Apr 2009). Author weblink.
  • Cobbold JF; Patel N; Goldin RD; Crossey ME; Morin SH; Fitzpatrick JA; Arridge M; Cox IJ; et alThomas HC; Cosgrove DO; Thursz MR; Leen EL; Taylor-Robinson SD. Early haemodynamic responses to interferon therapy in patients with chronic liver disease using contrast-enhanced ultrasound: Regulation by hepatic stellate cells?. 43rd Annual Meeting of the European-Association-for-the-Study-of-the-Liver. 48:S271-S271. (Feb 2008).
  • Cobbold JF; Chinthapalli S; Anstee Q; Goldin RD; Cox R; Thursz MR; Thomas HC; Taylor-Robinson SD; et alCox IJ. Dietary constituents in mice are reflected in the hepatic lipid profile as detected by carbon-13 magic angle spinning magnetic resonance spectroscopy. 58th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases. 46:764A-765A. (Oct 2007).
  • Cobbold JF; Anstee QM; Goldin RD; Cox RD; Thursz MR; Thomas HC; Taylor-Robinson SD; Cox IJ. Can disease progression in non-alcoholic fatty liver disease be predicted by metabolic biomarkers of lipid accumulation and peroxidation?. 42th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, 11 Apr 2007 - 15 Apr 2007. 46:S265-S265. ELSEVIER SCIENCE BV (1 Jan 2007). Author weblink DOI.
  • Cheong JLY; Rutherford MA; Counsell SJ; Cox IJ; Cowan FM; Robertson NJ. Longitudinal MR studies and outcome in neonatal encephalopathy. Annual Meeting of the European-Society-for-Paediatric-Research, 27 Sep 2003 - 30 Sep 2003. 54:590-590. INT PEDIATRIC RESEARCH FOUNDATION, INC (1 Oct 2003). Author weblink.
  • Hafez TS; Glantzounis GK; Cox IJ; Yang W; Seifalian AM; Fuller B; Davidson BR. N-acetylcysteine (NAC) and liver warm ischemia reperfusion injury: alterations to bile composition demonstrated by proton nuclear magnetic resonance spectroscopy (MRS). 3rd Meeting of the Society-of-Academic-and-Research-Surgery, Jan 2003. 90:604-604. WILEY-BLACKWELL (1 May 2003). Author weblink.
  • Khan SA; Cox IJ; Bansi D; Thillainayagam A; Thomas HC; Taylor-Robinson SD. Analysis of bile in patients with and without pancreaticobiliary malignancy by in vitro 31-phosphorus NMR spectroscopy. Annual meeting of the British-Society-of-Gastroenterology. 52:A92-A92. (Apr 2003).
  • Damelin LH; Cox IJ; Robertson NJ; Khalil M; Tootle R; Coward S; Choudhury S; Hodgson HJF; et alSelden C. Modulated mitochondrial activity corresponds with a decline in liver-specific function in 3-D HepG2 culture. 38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, 29 Mar 2003 - 1 Apr 2003. 38:193-193. ELSEVIER SCIENCE BV (1 Apr 2003). Author weblink DOI.
  • Hafez TS; Glantzounis GK; Cox IJ; Sheth H; Yang W; Seifalian AM; Fuller B; Davidson BR. N-acetylcysteine (NAC) and liver warm ischemia reperfusion injury: Alterations to bile composition demonstrated by proton nuclear magnetic resonance spectroscopy (MRS). 38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, 29 Mar 2003 - 1 Apr 2003. 38:39-40. ELSEVIER SCIENCE BV (1 Apr 2003). Author weblink DOI.
  • Robertson NJ; Bhakoo KK; Edwards AD; Cox IJ. Amiloride acidities and preserves NTP in neonatal rat brain slices. Meeting of the European-Society-for-Paediatric-Research. 52:811-811. (Nov 2002).
  • Robertson NJ; Bhakoo KK; Edwards AD; Cox IJ. Neuronal and glial pH(i): An ex vivo study of neonatal rat brain slices. Meeting of the European-Society-for-Paediatric-Research, 4 Sep 2002 - 7 Sep 2002. 52:811-811. INT PEDIATRIC RESEARCH FOUNDATION, INC (1 Nov 2002). Author weblink.
  • Robertson NJ; Bhakoo KK; Edwards AD; Cox IJ. Secondary energy failure in a neonatal rat brain slice model. Meeting of the European-Society-for-Paediatric-Research. 52:811-811. (Nov 2002).
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook